If hyperglycemia were to recur, this patient would be a candidate for oral sulfonylurea therapy as oral sulfonylureas have been shown to result in improved glycemic control in patients with diabetes due to KCNJ11 mutations (9,23,30). This evidence concerns the gene KCNJ11 and diabetes mellitus.